Apologies if this has already been posted. Unlike Hottod, I struggle to keep track of these things and it just came up on my feed even though its from last month.. (Note: Graphic Pics)
Fes
(PDF) Microsurgical Reconstruction of Foot Defects: A Case Series with Long-Term Follow-Up (researchgate.net)
In our clinic, the frequency of free flaps for reconstruction of foot defects has decreased due to the possibility of reconstructing complex defects, even in weight-bearing areas (such as the heel) using innovative treatment options from the field of dermal skin substitutes. A meta-analysis showed a reduced amputation rate in diabetic foot ulcers when treated with skin substitutes [29]. With NovoSorb® Biodegradable Temporising Matrix (BTM) (Poly-medics Innovations GmbH, Denkendorf, Germany), even deep wounds can be treated [30].However, skin substitutes, such as BTM, also have their limitations, notably in cases of poor vascularization or possible infectious events in the defect area, for example [30]. Following these findings, there may be a future balancing act between novel skin substitutes and autologous reconstruction procedures for large defects of the foot [19]. Influencing factors, such as comorbidities, status of bones, and the threat of losing another limb in the near future, need to be considered before choosing the best treatment option for every individual patient [31]. In principle, however, flap reconstructions are suitable for threatened ischemic lower extremities (in combination with revascularization procedures), traumatic defects(including burns), tumors, and infectionsIn our clinic, the frequency of free flaps for reconstruction of foot defects has decreaseddue to the possibility of reconstructing complex defects, even in weight-bearing areas (suchas the heel) using innovative treatment options from the field of dermal skin substitutes. Ameta-analysis showed a reduced amputation rate in diabetic foot ulcers when treated withskin substitutes [29].With NovoSorb®Biodegradable Temporising Matrix (BTM) (Poly-medics Innovations GmbH, Denkendorf, Germany), even deep wounds can be treated [30].However, skin substitutes, such as BTM, also have their limitations, notably in cases of poorvascularization or possible infectious events in the defect area, for example [30]. Followingthese findings, there may be a future balancing act between novel skin substitutes andautologous reconstruction procedures for large defects of the foot [19]. Influencing factors,such as comorbidities, status of bones, and the threat of losing another limb in the nearfuture, need to be considered before choosing the best treatment option for every individualpatient [31]. In principle, however, flap reconstructions are suitable for threatened ischemiclower extremities (in combination with revascularization procedures), traumatic defects(including burns), tumors, and infections
- Forums
- ASX - By Stock
- PNV
- PNV Media Thread
PNV Media Thread, page-2310
-
-
- There are more pages in this discussion • 933 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PNV (ASX) to my watchlist
|
|||||
Last
$2.61 |
Change
0.090(3.57%) |
Mkt cap ! $1.801B |
Open | High | Low | Value | Volume |
$2.59 | $2.66 | $2.58 | $3.183M | 1.217M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 19229 | $2.61 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.62 | 3084 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15952 | 2.610 |
2 | 1339 | 2.600 |
1 | 1945 | 2.570 |
1 | 5859 | 2.560 |
1 | 1636 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.620 | 1636 | 1 |
2.630 | 3333 | 2 |
2.640 | 1636 | 1 |
2.650 | 19763 | 3 |
2.660 | 26946 | 5 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |